Emily S Ruiz, MD, FAAD
SESSIONS
F049 Respect the Dormant Beast: Optimize Your Management of High-risk Cutaneous SCCs
Mar 8, 2025
•
3:30 PM - 5:30 PM
•
W208A
U064 JAAD Game Changers
Mar 9, 2025
•
8:00 AM - 9:00 AM
•
W208A
U057 When to Put Down the Scalpel: Non-surgical Therapies for Skin Cancer
Mar 9, 2025
•
8:00 AM - 9:00 AM
•
W202C
S064 How Would You Reconstruct It
Mar 10, 2025
•
1:00 PM - 4:00 PM
•
W311A
DISCLOSURES
Almirall – Consultant (1099 relationship)(Fees); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Checkpoint Therapeutics – Consultant (1099 relationship)(Fees); Feldan Therapeutics – Consultant (1099 relationship)(Fees); Merck – Investigator(Grants/Research Funding); Regeneron – Advisory Board(Fees), Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees), Consultant (1099 relationship)(Fees);